logo
Select company
Select metric
$ -14.51MNet Cash Flow - Operations
VS
Market
19
Sector
50
Industry
71
History
41
$ 0.8Close
$ 0.68 - $ 2.3 52-Week Range
Ticker Information

Ticker

LGVN

Company Name

LONGEVERON INC

Sector

Healthcare

Industry

Biotechnology

Exchange

NASDAQ

LONGEVERON INC - Net Cash Flow - Operations Chart Analysis (TTM)

From
Zoom
1Y
3Y
5Y
10Y

LGVN - CF - Operations Historical data
DateNet Cash Flow - Operations
6/30/2025$ -14.51M
3/31/2025$ -15.48M
12/31/2024$ -13.87M
9/30/2024$ -14.49M
6/30/2024$ -16.2M
3/31/2024$ -16.24M
12/31/2023$ -19M
9/30/2023$ -17.31M
6/30/2023$ -16.99M
3/31/2023$ -15.66M
Previous (option currently disabled)
1 (current)
Next (option currently disabled)

Key Performance Insights, Last 5 Years

  • LONGEVERON INC's latest trailing twelve months (TTM) CF - Operations stands at $ -2.39M.
  • Over the past 5 years, LONGEVERON INC's average CF - Operations has been $ -12.88M.
  • The median CF - Operations for LONGEVERON INC during this period was $ -14.23M
  • LONGEVERON INC reached its highest CF - Operations over the past 5 years at $ -2.36M.
  • The lowest CF - Operations recorded by LONGEVERON INC in the same timeframe $ -19M

LONGEVERON INC's CF - Operations vs. competitors

We picked the following companies as peers based on multiple factors, including sector, industry, market capitalization and revenue

CF - Operations Benchmarks
CompanyCF - Operations
CYCN : CYCLERION THERAPEUTICS INC $ -2.83MTRAW : TRAWS PHARMA INC $ -26.93MLYRA : LYRA THERAPEUTICS INC $ -43.01MERNA : ERNEXA THERAPEUTICS INC $ -14.43MBRTX : BIORESTORATIVE THERAPIES INC $ -9.52MAPRE : APREA THERAPEUTICS INC $ -12.74MXBIO : XENETIC BIOSCIENCES INC $ -2.52MTXMD : THERAPEUTICSMD INC $ -243KLUCY : INNOVATIVE EYEWEAR INC $ -7.77MLEXX : LEXARIA BIOSCIENCE CORP $ -9.7M

Definition of Net Cash Flow - Operations

[Cash Flow Statement] Cash flow from operations represents the amount of cash inflow (outflow) that a company generates (consumes) from operating activities. Similar to Net Income [NetIncCmn] but harder to manipulate and ignoring effects of non-cash charges like depreciation.

LGVN - Net Cash Flow - Operations, Last 5 years

$ -19M

Minimum

Dec 31, 2023

$ -2.36M

Maximum

Dec 31, 2020

$ -12.88M

Average

$ -14.23M

Median

CF - Operations Benchmark Analysis

The chart above depicts the distribution of CF - Operations for companies in the Total Stock Market. The average CF - Operations of the companies is $ 58.3M with a standard deviation of $ 142.13M.
The following table provides additional summary stats:
CF - Operations in the Market:
filtered constituents3.26K
min$ -406M
max$ 508.1M
average$ 58.3M
median$ 10.91M
std$ 142.13M